Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-25
DOI
10.1038/s41598-017-01353-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer
- (2015) Chang-Han Chen et al. Molecular Cancer
- Dysregulation of Wnt-Signaling and a Candidate Set of miRNAs Underlie the Effect of Metformin on Neural Crest Cell Development
- (2015) Poulomi Banerjee et al. STEM CELLS
- Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model
- (2015) Devaraja Rajasekaran et al. Oncotarget
- Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
- (2015) Chih-Yen Chien et al. Oncotarget
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal
- (2014) L. Li et al. CLINICAL CANCER RESEARCH
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
- (2013) J A C M Goos et al. BRITISH JOURNAL OF CANCER
- Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma
- (2013) Vlad C. Sandulache et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Pin1 acts as a negative regulator of the G2/M transition by interacting with the Aurora-A-Bora complex
- (2013) Y.-C. Lee et al. JOURNAL OF CELL SCIENCE
- Aurora kinases in head and neck cancer
- (2013) Ranee Mehra et al. LANCET ONCOLOGY
- Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
- (2013) Morgan D Fullerton et al. NATURE MEDICINE
- Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis
- (2013) Chung-Feng Hwang et al. PLoS One
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- Overexpression of Rap-1A Indicates a Poor Prognosis for Oral Cavity Squamous Cell Carcinoma and Promotes Tumor Cell Invasion via Aurora-A Modulation
- (2012) Chang-Han Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
- (2012) Makoto Taga et al. International Journal of Biological Sciences
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
- (2012) K. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Targeting late SV40 factor: Is the achilles heel of hepatocarcinogenesis revealed?
- (2012) Amir Shlomai WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- In vitro and in vivo anti-melanoma action of metformin
- (2011) Kristina Janjetovic et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)
- (2011) Prasanna K. Santhekadur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF
- (2011) Byoung Kwon Yoo et al. JOURNAL OF HEPATOLOGY
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity
- (2010) Chung-Feng Hwang et al. JOURNAL OF PATHOLOGY
- Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma
- (2010) B. K. Yoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
- (2008) Vuk Stambolic et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity
- (2007) Chih-Yen Chien et al. JOURNAL OF SURGICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started